KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sarepta Therapeutics (SRPT) Change in Inventory (2016 - 2025)

Sarepta Therapeutics has reported Change in Inventory over the past 10 years, most recently at -$18.5 million for Q4 2025.

  • Quarterly results put Change in Inventory at -$18.5 million for Q4 2025, down 111.43% from a year ago — trailing twelve months through Dec 2025 was $301.1 million (down 23.81% YoY), and the annual figure for FY2025 was $301.1 million, down 23.81%.
  • Change in Inventory for Q4 2025 was -$18.5 million at Sarepta Therapeutics, down from $83.0 million in the prior quarter.
  • Over the last five years, Change in Inventory for SRPT hit a ceiling of $177.4 million in Q1 2025 and a floor of -$18.5 million in Q4 2025.
  • Median Change in Inventory over the past 5 years was $27.0 million (2021), compared with a mean of $48.9 million.
  • Biggest five-year swings in Change in Inventory: surged 19675.16% in 2024 and later tumbled 111.43% in 2025.
  • Sarepta Therapeutics' Change in Inventory stood at $27.3 million in 2021, then crashed by 67.43% to $8.9 million in 2022, then skyrocketed by 959.73% to $94.1 million in 2023, then surged by 71.79% to $161.7 million in 2024, then plummeted by 111.43% to -$18.5 million in 2025.
  • The last three reported values for Change in Inventory were -$18.5 million (Q4 2025), $83.0 million (Q3 2025), and $59.2 million (Q2 2025) per Business Quant data.